Showing results (361-370 of 651) with videos related to

Sort By:
Pageof 66
Neuropsychopharmacology Reports|August 15, 2018
Behavioral effects of long-term oral administration of aluminum ammonium sulfate in male and female C57BL/6J miceHirotaka Shoji, Yasuhiro Irino, Masaru Yoshida, et al.
Neuropsychopharmacology Reports|August 31, 2025
The Impact of Adjunctive Aripiprazole on Olanzapine-Induced Metabolic Adverse Effects in Patients With Schizophrenia: A Systematic ReviewStephen Simmons, Soban Sadiq
Neuropsychopharmacology Reports|April 17, 2023
The relationship between dietary patterns and insomnia in young womenSamira Karbasi, Zahra Asadi, Zabihullah Mohaghegh, et al.
Neuropsychopharmacology Reports|August 7, 2020
Electroencephalographic characteristics of word finding during phonological and semantic verbal fluency tasksNajva Mousavi, Mohammad Ali Nazari, Jalil Babapour, et al.
Neuropsychopharmacology Reports|April 14, 2023
The new guideline for evaluating effects of psychotropic drugs on the performance to drive a motor vehicle in Japan: Comparison with US FDA guidelineKunihiro Iwamoto, Tetsuo Nakabayashi, Akiko Yamaguchi, et al.
Neuropsychopharmacology Reports|May 19, 2023
Association of two variable number of tandem repeats in the monoamine oxidase A gene promoter with suicide completion: The present study and meta-analysisMasashi Hasegawa, Takaki Tanifuji, Satoshi Okazaki, et al.
Neuropsychopharmacology Reports|July 1, 2020
Prescription patterns in patients with schizophrenia in Japan: First-quality indicator data from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" projectKayo Ichihashi, Hikaru Hori, Naomi Hasegawa, et al.
Neuropsychopharmacology Reports|April 6, 2021
Future direction of addiction research-An expert questionnaire survey in JapanHiromi Takahashi-Omoe, Soichiro Ide, Hisatsugu Miyata, et al.
Neuropsychopharmacology Reports|May 16, 2023
A single site study to investigate the current prevalence of anti-hepatitis C virus antibody among substance use disorder patients in Hiroshima-Insufficient testing and diagnosisAriyuki Kagaya, Yuko Nagaoki, Satomi Shimura, et al.
Neuropsychopharmacology Reports|November 28, 2019
Decreased serum levels of thrombospondin-1 in female depressed patientsMami Okada-Tsuchioka, Wataru Omori, Naoto Kajitani, et al.
Pageof 66